OBSERVATIONAL CLINICAL STUDY PROTOCOL An Observational Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed with Early-Onset Idiopathic Bilateral Cataracts
L
Linda Morgan
Primary Investigator
D
David Plager, MD
Primary Investigator
Overview
The purpose of this study is to understand better how many people who have been diagnosed with early-onset idiopathic bilateral cataracts may have a rare but treatable disease called Cerebrotendinous Xanthomatosis.
Description
The purpose of this study is to understand better how many people who have been diagnosed with early-onset idiopathic bilateral cataracts may have a rare but treatable disease called Cerebrotendinous Xanthomatosis.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Cerebrotendinous Xanthomatosis,diopathic Bilateral Cataracts,1603098846
-
Age: - 100 Years
-
Gender: All
Updated on
20 Nov 2022.
Study ID: 1603098846
